Skip to main content
logo
Hikma Pharmaceuticals PLC (LON:HIK)
London flag London · Delayed Price · Currency is GBP · Price in GBp
1,985.00
-13.00 (-0.65%)
Jul 22, 2025, 4:35 PM BST

Hikma Pharmaceuticals Revenue

In the year 2024, Hikma Pharmaceuticals had annual revenue of $3.13B USD with 8.77% growth. Hikma Pharmaceuticals had revenue of $1.56B in the half year ending December 31, 2024, with 19.48% growth.

Revenue
$3.13B
Revenue Growth
+8.77%
P/S Ratio
1.75
Revenue / Employee
$329.16K
Employees
9,500
Market Cap
4.38B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.13B252.00M8.77%
Dec 31, 20232.88B358.00M14.22%
Dec 31, 20222.52B-36.00M-1.41%
Dec 31, 20212.55B212.00M9.06%
Dec 31, 20202.34B134.00M6.07%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca42.56B
GSK plc31.53B
Haleon11.23B
Smith & Nephew4.64B
ConvaTec Group1.83B
HUTCHMED (China)503.39M
Oxford Nanopore Technologies183.19M
Genus671.60M
Revenue Rankings

Hikma Pharmaceuticals News

More News